268 filings
Page 3 of 14
8-K
iv86pr7pnarxoxn 3j2m
7 Feb 23
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
4:20pm
8-K
xv6d6x99
9 Jan 23
January 2023 Larimar Therapeutics Corporate Presentation
4:03pm
EFFECT
cs3dc
22 Nov 22
Notice of effectiveness
12:15am
CORRESP
06c6mq63edlna8
18 Nov 22
Correspondence with SEC
12:00am
UPLOAD
y6ia jktkl
16 Nov 22
Letter from SEC
12:00am
8-K
vu8u6a601u2wx3l7y
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
lruqnhid530761 qex4
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
48pg39128 ysu3
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
rr0xp
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
k74eh l7e8
14 Sep 22
Other Events
7:05am
8-K
pa6vy7r
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
zay4pfe5vi1zj2nlp
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
hq4its0aouh2zjr
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
otaqym
11 Apr 22
Departure of Directors or Certain Officers
4:06pm